How to Spot a Questionable Clinical Trial

Public registries like ClinicalTrials.gov list studies as they are submitted. Being listed is not a stamp of approval, and no one checks each entry to confirm it is safe or well designed. The vast majority of listings come from careful, well-run research. But a small number look polished while lacking the safeguards that protect participants, and those are the ones worth slowing down for.

Four warning signs to look for

1. No independent safety oversight

Well-run trials have a Data Monitoring Committee, an independent group that reviews the data as the study runs and can pause or stop it if participants are being harmed. If no one outside the research team is watching for safety, that is a warning sign.

2. No comparison group and no blinding

A single group with nothing to compare against, where everyone knows they are getting the treatment, makes it harder to tell whether any change came from the treatment itself or from hope, attention, or chance. There is an important exception: early-phase safety trials, including first-in-human surgical, cell, and gene therapies, are often single-arm and open-label by design, because their first job is to check safety rather than to prove the treatment works. So this feature on its own is not a red flag. It matters most in later-phase trials meant to prove a treatment works, or when it appears alongside the other signs here. Strong efficacy studies compare groups and, where possible, keep participants and researchers blinded to who got what.

3. An unaccountable sponsor, or a single private clinic

Established companies, universities, and government agencies answer to regulators and ethics review boards. A single private clinic, sometimes offshore, running its own experimental therapy with no larger institution behind it has far less accountability if something goes wrong. Location is the signal a family can most easily check for themselves: a legitimate trial usually runs at several sites, often across more than one country, while medical tourism tends to point to one private clinic, sometimes in a place chosen for lighter oversight. If the only site is a single private clinic, that is worth questioning.

4. Outside regulator oversight, or asking you to pay

Legitimate trials are overseen by a medicines regulator, and they do not charge you to take part. A study that operates outside that oversight, or that asks you to pay to be a participant, deserves serious scrutiny. Being asked to pay for an experimental treatment is one of the strongest red flags there is.

A treatment type is not a red flag

Stem cell, gene therapy, and other advanced approaches are at the heart of legitimate, carefully run Parkinson's research. The concern is never the type of treatment on its own. It is the absence of the safeguards above. Many of the most promising trials use exactly these methods, with full oversight. If you want to understand the real science, start with our guide to stem cell therapy for Parkinson's.

A worked example

The clearest example on our own site is a study testing exosomes, tiny cell-derived particles, as a therapy for Parkinson's. You can see the full listing, with our caution note attached, at listing NCT05152394. Exosomes are an active research area, but they are not a settled, approved therapy: the U.S. Food and Drug Administration has issued public safety warnings about unapproved exosome products being marketed to patients, after reports of serious harm. No exosome product is FDA-approved to treat any condition. That is one reason this listing falls into the caution category. It shows the pattern this whole guide is about: an unproven product offered outside the usual regulatory pathway, without the independent oversight and controlled design that protect participants in well-run trials. Seeing the listing is useful precisely because it shows how a study can look scientific and polished while still missing the safeguards that matter most.

What we do with these listings

When a study shows this pattern, we keep it out of the default trial list and our matching tools, so it does not get recommended as if it were vetted. The listing stays reachable by direct link and search, with a caution note, so you can still read it and make an informed decision with your own doctor. This is never a judgment of a specific treatment, only a prompt to ask more questions.